Clinical Trials Directory

Trials / Completed

CompletedNCT00877331

Brief Intervention in Primary Care for Problem Drug Use and Abuse

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
868 (actual)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will examine the effectiveness of a brief intervention in a primary care setting to reduce drug use or abuse compared to enhanced care as usual.

Detailed description

A substantial body of research has established the efficacy and effectiveness of brief interventions (BI) for excessive or "hazardous" alcohol use in patients seen in medical settings. Dissemination projects of brief interventions for alcohol and drugs have recently been implemented on a widespread scale. This rapid progression of brief intervention for drugs other than alcohol has outstripped its evidence base. The aims of the study as outlined in the grant are: 1. To examine whether BI is effective at improving outcomes (self-reported drug use and attendance in drug abuse treatment) in individuals with a wide range of problem drug use over and above enhanced care as usual. The enhanced control condition will consist of routine screening, patient notification, and referral for treatment. 2. To test whether fidelity to the BI model or lower severity of drug use is associated with better outcomes. 3. To estimate the impact of BI on several public health outcomes that are directly related to the hazardous effects of illicit drug use, including the use of acute health care services, involvement in the criminal justice system, employment, HIV risk behavior, and mortality. 4. To estimate the costs of the intervention, potential cost offsets, and its incremental cost-effectiveness versus enhanced usual care from the payer perspective based on health care service use and drug use frequency.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBrief intervention using motivational interviewingOne brief, in-person motivational interviewing session (30-45 minutes) in conjunction with the medical appointment. Plus one brief follow-up phone call one week later.

Timeline

Start date
2009-04-01
Primary completion
2013-10-01
Completion
2014-09-01
First posted
2009-04-07
Last updated
2014-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00877331. Inclusion in this directory is not an endorsement.